Form CORRESP - Correspondence:
SEC Accession No. 0001213900-24-101587
Filing Date
2024-11-22
Accepted
2024-11-22 16:01:21
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 6497
2 GRAPHIC image_001.jpg GRAPHIC 3037
  Complete submission text file 0001213900-24-101587.txt   12060
Mailing Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025
Business Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025 650-606-7910
Oruka Therapeutics, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)